Asimtufii

aripiprazole monohydrate · Otsuka Pharmaceutical Netherlands B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Asimtufii, covering 2023-07-07 to 2023-07-07. Get the full timeline:

Most recent: EMA Application withdrawn: Asimtufii (aripiprazole monohydrate) — Otsuka Pharmaceutical Netherlands B.V.